Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.

“So, if we can show an association between specific chemicals and lymphoma in dogs, that might help us understand how nonsmoking people who don’t have other risks for non-Hodgkin’s lymphoma ...

a CD19-redirected ARTEMIS ® T-cell therapy to treat patients with Advanced B-Cell Non-Hodgkin’s Lymphomas (NHL). The second cohort will evaluate EB103 at a higher dose level following a review ...

Online abuse and threats directed toward athletes are increasing as mobile sports betting grows in popularity.

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that the results from the open label Phase 2 PROSPECT Study of tirabrutinib is to be ...

The study met its co-primary safety and efficacy endpoints, with BrECADD demonstrating significantly superior safety as assessed by treatment-related morbidity (TRMB) and non ... s approval represents ...

In NOD/SCID mice transplanted intraperitoneally with human non-Hodgkin's lymphoma (NHL) cell lines, Namalwa, RAP1-EIO and HS-Sultan, green tea prevented 50% of Namalwa tumors (P = 0.0017 by log ...

When Portland Trail Blazers owner Paul Allen died in 2018 from complications related to non-Hodgkin’s lymphoma, it was matter of when, not if, his beloved professional sports team would be sold.

A study to learn more about how safe the combination of copanlisib with standard treatment is and whether it works in participants with relapsed indolent non-Hodgkin’s lymphoma Bayer Clinical Trials ...